« Return to News | Ethics/Regulatory

Coast IRB Halts New Study Submissions

Wednesday, April 15, 2009 07:53 AM

Facing FDA concerns about its ability to protect human subjects participating in clinical trials, Coast Institutional Review Board has voluntarily suspended the approval of new studies as well as the recruitment of new patients for ongoing studies.

These actions may involve up to 300 active trials conducted by 3,000 clinical investigators, the FDA announced yesterday. Studies that Coast IRB already has approved will be permitted to continue but no new patients will be enrolled.

Coast, which was recently the target of an undercover investigation by the Government Accountability Office, received a warning letter from the FDA outlining five “serious violations” and calling for reform.

Coast announced last week a 30-day suspension of the processing of new study submissions and has hired a consulting firm to audit its operations, SOPs and forms. Coast has said it will return to the FDA with a corrective action plan by the end of this month.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.